FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899154987> ?p ?o ?g. }

• W2899154987 endingPage "10" @default.
• W2899154987 startingPage "1" @default.
• W2899154987 abstract "The eighth annual conference of Innovative therapy, monoclonal antibodies, and beyond was held in Milan on Jan. 26, 2018, and hosted by Fondazione IRCCS-Istituto Nazionale dei Tumori (Fondazione IRCCS INT). The conference was divided into two main scientific sessions, of i) pre-clinical assays and novel biotargets, and ii) clinical translation, as well as a third session of presentations from young investigators, which focused on recent achievements within Fondazione IRCCS INT on immunotherapy and targeted therapies. Presentations in the first session addressed the issue of cancer immunotherapy activity with respect to tumor heterogeneity, with key topics addressing: 1) tumor heterogeneity and targeted therapy, with the definition of the evolutionary Index as an indicator of tumor heterogeneity in both space and time; 2) the analysis of cancer evolution, with the introduction of the TRACERx Consortium-a multi-million pound UK research project focused on non-small cell lung cancer (NSCLC); 3) the use of anti-estrogen agents to boost immune recognition of breast cancer cells; and 4) the high degree of functional plasticity within the NK cell repertoire, including the expansion of adaptive NK cells following viral challenges. The second session addressed: 1) the effectiveness of radiotherapy to enhance the proportion of patients responsive to immune-checkpoint blockers (ICBs); 2) the use of MDSC scores in selecting melanoma patients with high probability to be responsive to ICBs; and 3) the relevance of the gut microbiome as a predictive factor, and the potential of its perturbation in increasing the immune response rate to ICBs. Overall, a picture emerged of tumor heterogeneity as the main limitation that impairs the effectiveness of anti-cancer therapies. Thus, the choice of a specific therapy based on reproducible and selective predictive biomarkers is an urgent unmet clinical need that should be addressed in order to increase the proportion of long-term responding patients and to improve the sustainability of novel drugs." @default.
• W2899154987 created "2018-11-09" @default.
• W2899154987 creator A5000073229 @default.
• W2899154987 creator A5000391768 @default.
• W2899154987 creator A5001910485 @default.
• W2899154987 creator A5009935310 @default.
• W2899154987 creator A5012155282 @default.
• W2899154987 creator A5013009758 @default.
• W2899154987 creator A5016966644 @default.
• W2899154987 creator A5030663884 @default.
• W2899154987 creator A5036575248 @default.
• W2899154987 creator A5042737704 @default.
• W2899154987 creator A5044426445 @default.
• W2899154987 creator A5053389850 @default.
• W2899154987 creator A5056525592 @default.
• W2899154987 creator A5066576514 @default.
• W2899154987 creator A5069765350 @default.
• W2899154987 creator A5074612242 @default.
• W2899154987 creator A5079437223 @default.
• W2899154987 creator A5083469846 @default.
• W2899154987 creator A5088581133 @default.
• W2899154987 date "2018-12-01" @default.
• W2899154987 modified "2023-10-12" @default.
• W2899154987 title "Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting" @default.
• W2899154987 cites W1778071429 @default.
• W2899154987 cites W1868131768 @default.
• W2899154987 cites W1914685501 @default.
• W2899154987 cites W1995824006 @default.
• W2899154987 cites W2003099302 @default.
• W2899154987 cites W2011850791 @default.
• W2899154987 cites W2013435992 @default.
• W2899154987 cites W2018105494 @default.
• W2899154987 cites W2022837929 @default.
• W2899154987 cites W2023630186 @default.
• W2899154987 cites W2025421597 @default.
• W2899154987 cites W2043161337 @default.
• W2899154987 cites W2071255079 @default.
• W2899154987 cites W2074390009 @default.
• W2899154987 cites W2098337213 @default.
• W2899154987 cites W2099044540 @default.
• W2899154987 cites W2100439220 @default.
• W2899154987 cites W2107027410 @default.
• W2899154987 cites W2107426197 @default.
• W2899154987 cites W2116170249 @default.
• W2899154987 cites W2126547130 @default.
• W2899154987 cites W2127527009 @default.
• W2899154987 cites W2129278872 @default.
• W2899154987 cites W2131884978 @default.
• W2899154987 cites W2146313292 @default.
• W2899154987 cites W2148067809 @default.
• W2899154987 cites W2149415083 @default.
• W2899154987 cites W2149952321 @default.
• W2899154987 cites W2151259830 @default.
• W2899154987 cites W2158809810 @default.
• W2899154987 cites W2165456770 @default.
• W2899154987 cites W2166400927 @default.
• W2899154987 cites W2266683146 @default.
• W2899154987 cites W2293494611 @default.
• W2899154987 cites W2402636472 @default.
• W2899154987 cites W2415990680 @default.
• W2899154987 cites W2462121348 @default.
• W2899154987 cites W2493219106 @default.
• W2899154987 cites W2535069604 @default.
• W2899154987 cites W2554098255 @default.
• W2899154987 cites W2556376431 @default.
• W2899154987 cites W2560717039 @default.
• W2899154987 cites W2568946517 @default.
• W2899154987 cites W2575161424 @default.
• W2899154987 cites W2586629973 @default.
• W2899154987 cites W2612325658 @default.
• W2899154987 cites W2729948424 @default.
• W2899154987 cites W2737435265 @default.
• W2899154987 cites W2738309976 @default.
• W2899154987 cites W2753065806 @default.
• W2899154987 cites W2753432434 @default.
• W2899154987 cites W2753965489 @default.
• W2899154987 cites W2766149732 @default.
• W2899154987 cites W2766209631 @default.
• W2899154987 cites W2766931469 @default.
• W2899154987 cites W2772360708 @default.
• W2899154987 cites W2773022455 @default.
• W2899154987 cites W2778808161 @default.
• W2899154987 cites W2784164696 @default.
• W2899154987 cites W2788578140 @default.
• W2899154987 cites W2794616539 @default.
• W2899154987 cites W2802695384 @default.
• W2899154987 cites W2947495476 @default.
• W2899154987 cites W2951890973 @default.
• W2899154987 doi "https://doi.org/10.1016/j.cytogfr.2018.10.005" @default.
• W2899154987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30393044" @default.
• W2899154987 hasPublicationYear "2018" @default.
• W2899154987 type Work @default.
• W2899154987 sameAs 2899154987 @default.
• W2899154987 citedByCount "1" @default.
• W2899154987 countsByYear W28991549872019 @default.
• W2899154987 crossrefType "journal-article" @default.
• W2899154987 hasAuthorship W2899154987A5000073229 @default.
• W2899154987 hasAuthorship W2899154987A5000391768 @default.

• next